Drug profile · INN
albendazole
ESKAZOLE
albendazole (ESKAZOLE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — albendazole
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 3
- Data quality
- 0.84
Quick answer
albendazole (ESKAZOLE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is albendazole?
albendazole (ESKAZOLE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for albendazole?
ESKAZOLE is a marketed brand name for albendazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of albendazole?
albendazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.